文献速递临床试验与 GCP

住院患者皮下隧道式与外周静脉置入中心静脉导管常规置入的比较(TUNNEL-PICC):一项随机对照试验的研究方案

Subcutaneous tunnelling versus conventional insertion of peripherally inserted central catheters in hospitalized patients (TUNNEL-PICC): a study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2022-09-15

TUNNEL-PICC为多机构、前瞻性、非盲实用性随机对照试验,计划纳入五家转诊医院的1694例患者,按计算机生成的分层随机分为常规PICC组与皮下隧道式PICC组,主要终点为皮下隧道是否降低CLABSI发生率,次要终点包括技术成功率、出口部位出血或感染等并发症及操作时间。

要点

  • 皮下隧道用于中心静脉导管可降低CLABSI风险,但尚未在PICC置入中普遍采用。
  • TUNNEL-PICC为多机构前瞻性非盲实用性随机对照试验,计划纳入1694例患者。
  • 主要终点为皮下隧道对比常规方法是否降低CLABSI发生率。

核心结论

  • TUNNEL-PICC试验将为皮下隧道降低PICC置入中CLABSI风险的有效性提供证据。

研究设计与样本

  • 多机构、前瞻性、非盲实用性随机对照试验,计划纳入五家转诊医院的1694例患者。
  • 采用计算机生成的分层随机将患者分配至常规PICC组与皮下隧道式PICC组两个平行组。
  • 常规组按常规实践置入PICC,皮下隧道式PICC组额外实施皮下隧道。
  • 随访至PICC拔除或本研究结束。

主要发现

  • 主要终点为皮下隧道对比常规方法是否降低CLABSI发生率。
  • 次要终点为两组间技术成功率、包括出口部位出血或感染在内的并发症及操作时间。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Peripherally inserted central catheters (PICCs) are now widely used in modern medicine, and associated complications have also increased. Central line-associated bloodstream infection (CLABSI) is the most serious complication because it can cause extended hospital stays and increase costs. Furthermore, it can contribute to dire consequences for critically ill patients. Subcutaneous tunnelling for central venous catheters is an accepted method to reduce the risk of CLABSI. However, it is not generally adopted for PICC placement in most hospitals because its safety and efficacy have not been thoroughly evaluated. METHODS: In this multi-institutional, prospective, non-blinded pragmatic randomized controlled trial, 1694 patients treated at five referral hospitals will be assigned to one of two parallel arms (conventional and tunnelled PICC groups) using computer-generated stratified randomization. The conventional group will undergo PICC placement by routine practice. In the tunnelled PICC (tPICC) group, additional subcutaneous tunnelling will be applied. Patients will be followed until PICC removal or the end of this study. The primary endpoint is whether subcutaneous tunnelling reduced the rate of CLABSI compared to the conventional method. The secondary endpoints are technical success rates, complications including exit-site bleeding or infection, and the procedure time between the groups. DISCUSSION: Subcutaneous tunnelling is a widely used method to reduce catheter-associated infection. However, it has not been thoroughly applied for PICC. A randomized trial is needed to objectively assess the effects of the subcutaneous tunnel in PICC placement. This TUNNEL-PICC trial will provide evidence for the effectiveness of subcutaneous tunnelling in decreasing the risk of CLABSI. TRIAL REGISTRATION: Clinical Research Information Service (CRiS) KCT0005521.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kwon Y, Kim ET, Cho SB, et al. Subcutaneous tunnelling versus conventional insertion of peripherally inserted central catheters in hospitalized patients (TUNNEL-PICC): a study protocol for a randomized controlled trial. Trials. 2022. PMID: 36109819. doi:10.1186/s13063-022-06682-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。